OTIS W BRAWLEY Insider Profile
11 Followers
OTIS W BRAWLEY, Director at Lyell Immunopharma, holds 1.78K shares in Lyell Immunopharma (Ticker: LYEL), holds ― shares in PDS Biotechnology (Ticker: PDSB), holds 12.89K shares in Incyte (Ticker: INCY). Most recently, OTIS W BRAWLEY Bought ― shares of Lyell Immunopharma on Apr 02, 2025 for an estimated value of $19.96K.
OTIS W BRAWLEY has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that OTIS W BRAWLEY holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by OTIS W BRAWLEY
OTIS W BRAWLEY's Trading History
Lyell Immunopharma
Apr 02, 2025
Director
Informative Buy
19.96K
$25.61K
PDS Biotechnology
―
Director
―
―
Incyte
Jun 10, 2026
Director
Uninformative Buy
―
$1.63M
Agilent
Mar 23, 2026
Director
Uninformative Buy
340.39K
$2.09M
List of latest transactions for each holding click on a transaction to see OTIS W BRAWLEY's performance on stock
You May Also Like
OTIS W BRAWLEY insider profile FAQ
What is the percentage of profitable transactions made by OTIS W BRAWLEY?
The percentage of profitable transactions made by OTIS W BRAWLEY is ―.
What is the average return per transaction made by OTIS W BRAWLEY?
The average return per transaction made by OTIS W BRAWLEY is ―.
What stocks does OTIS W BRAWLEY hold?
OTIS W BRAWLEY holds: LYEL, PDSB, INCY, A stocks.
What was OTIS W BRAWLEY’s latest transaction?
OTIS W BRAWLEY latest transaction was an Informative Buy of $19.96K.
What was OTIS W BRAWLEY's most profitable transaction?
OTIS W BRAWLEY’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is OTIS W BRAWLEY's role in Lyell Immunopharma?
OTIS W BRAWLEY's role in Lyell Immunopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.